Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.FiveStarEquities.com and get exclusive access to our numerous stock reports.
ANADIGICS, Inc. (NASDAQ: ANAD) shares spiked 16.11 percent to close at $2.09 a share Tuesday. The stock traded between $1.83 and $2.15 on volume of 3.27 million shares traded. The company has announced that Samsung has selected their power amplifiers for the new GALAXY Trend 3. Shares of ANADIGICS have fallen approximately 10.0 percent in the past year.
Get more information on ANADIGICS and free access to the in-depth equity report at:
www.FiveStarEquities.com/ANAD
Aviat Networks Inc. (NASDAQ: AVNW) shares dropped 15.70 percent to close at $1.88 a share Tuesday. The stock traded between $1.85 and $2.14 on volume 1.32 million shares traded. The company has lowered its revenue forecast for the second quarter of fiscal 2014 to a range of $83.0 million to $87.0 million due to lower sales in Africa. Shares of Aviat Networks have fallen approximately 40.0 percent in the past year.
Get more information on Aviat Networks and free access to the in-depth equity report at:
www.FiveStarEquities.com/AVNW
Lantronix Inc. (NASDAQ: LTRX) shares surged 29.221 percent to close at $2.30 a share Tuesday. The stock traded between $1.76 and $2.50 on volume 1.45 million shares traded. The company’s shares were lifted by Google’s recent $3.2 billion acquisition of Nest Labs. Shares of Lantronix have are up approximately 25.0 percent in the past year.
Get more information on Lantronix free access to the in-depth equity report at:
www.FiveStarEquities.com/LTRX
VIVUS, Inc. (NASDAQ: VVUS) shares gained 4.76 percent to close at $9.46 a share Tuesday. The stock traded between $9.27 and $9.80 on volume 4.61 million shares traded. The company announced that Aetna’s weight loss pilot program, which will run throughout 2014, will include Qsymia. Shares of VIVUS have fallen approximately 30.0 percent in the past year.
Get more information on VIVUS and free access to the in-depth equity report at:
www.FiveStarEquities.com/VVUS
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.
Contact:
Five Star Equities
[email protected]